Management of Soft Tissue Sarcomas
Summary
Soft tissue sarcomas represent a rare and diverse group of malignant tumours arising from mesenchymal tissues. Management hinges on accurate diagnosis, precise staging and coordinated care within specialist centres. Magnetic resonance imaging and core biopsy establish extent and histology, guiding treatment decisions. Surgical excision with clear margins remains the cornerstone of curative therapy, with the aim of R0 resection while preserving function. Radiotherapy—administered pre- or postoperatively—enhances local control, especially for high-grade or large lesions in the extremities. The role of chemotherapy is histology-dependent, offering benefit in selected subtypes and in the neoadjuvant or metastatic setting. Emerging targeted agents and immunotherapies are under evaluation for molecularly defined cohorts. Centralisation of care in multidisciplinary teams ensures adherence to guidelines, enables complex resections and flavoured reconstructive approaches, and optimises long-term surveillance for local recurrence and metastatic spread. Follow-up protocols balance early detection of relapse with quality-of-life considerations, reflecting global efforts to standardise outcomes while personalising treatment according to tumour biology and patient preference.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Management of Soft Tissue Sarcomas publication trend
The graph below shows the total number of articles in management of soft tissue sarcomas across all publications each year (not limited to Nature Index journals).
Technical terms
Neoadjuvant therapy: Treatment given before the main intervention, typically surgery, to shrink tumour burden.
Adjuvant therapy: Treatment administered after primary surgical resection to eliminate microscopic residual disease.
Surgical margin (R0/R1/R2): Classification of residual tumour at the resection boundary; R0 denotes no residual disease, R1 microscopic, R2 macroscopic.
Multidisciplinary team: A coordinated group of specialists—surgeons, oncologists, radiologists and pathologists—who jointly plan and deliver patient management.
References
- A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Cancer Treatment Reviews (2023).
- Guidelines for the Management of Soft Tissue Sarcomas. Sarcoma (2010).
- Survival impact of centralization and clinical guidelines for soft tissue sarcoma (A prospective and exhaustive population-based cohort). PLOS ONE (2017).
- Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy. Radiation Oncology (2016).
- Should Soft Tissue Sarcomas be Treated at a Specialist Centre?. Sarcoma (2004).
- Primary flap reconstruction of tissue defects after sarcoma surgery enables curative treatment with acceptable functional results: a 7-year review. BMC Surgery (2015).
- Margin Assessment in Soft Tissue Sarcomas: Review of the Literature. Cancers (2021).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.